Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| PTC THERAPEUTICS, INC. | 29,017 | reported | 09 Jun 2022 | tx 16+123,500−2,483 |
| Xenon Pharmaceuticals Inc. | 1,593 | reported | 03 Jun 2026 | tx 18+195,063−29,061 |
| ACELYRIN, Inc. | 0 | reported | 21 May 2025 | tx 11+309,094−464,544 |
| Global Blood Therapeutics, Inc. | 0 | reported | 05 Oct 2022 | tx 26+85,221−75,621 |
| ENDOCYTE INC | 0 | reported | 21 Dec 2018 | tx 6+49,050−49,050 |
| Avalanche Biotechnologies, Inc. | 0 | reported | 09 Dec 2025 | tx 15+235,970−42,470 |
| MEDIVATION, INC. | 0 | reported | 28 Sept 2016 | tx 18+30,167−109,030 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jun 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 2,645 | — | |
| 01 Jun 2026 | TAX_WITHHOLDING | Xenon Pharmaceuticals Inc. | 1,416 | 53.41 USD | |
| 01 Jun 2026 | EXERCISE | Xenon Pharmaceuticals Inc. | 2,645 | 0.00 USD | deriv |
| 03 Jun 2026 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 10,507 | 0.00 USD | deriv |
| 03 Jun 2026 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 1,593 | 0.00 USD | deriv |
| 09 Dec 2025 | TENDER | Avalanche Biotechnologies, Inc. | 5,000 | — | |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 4,000 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 4,000 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 4,500 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 4,000 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 10,520 | — | deriv |
| 09 Dec 2025 | OTHER | Avalanche Biotechnologies, Inc. | 10,450 | — | deriv |
| 17 Jun 2025 | GRANT_AWARD | Avalanche Biotechnologies, Inc. | 10,450 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 2,645 | 0.00 USD | deriv |
| 05 Jun 2025 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 17,012 | 0.00 USD | deriv |
| 21 May 2025 | OTHER | ACELYRIN, Inc. | 15,000 | — | |
| 21 May 2025 | OTHER | ACELYRIN, Inc. | 155,450 | — | deriv |
| 21 May 2025 | OTHER | ACELYRIN, Inc. | 92,158 | — | deriv |
| 21 May 2025 | OTHER | ACELYRIN, Inc. | 23,243 | — | deriv |
| 17 Jun 2024 | GRANT_AWARD | Avalanche Biotechnologies, Inc. | 10,520 | 0.00 USD | deriv |
| 07 Jun 2024 | GRANT_AWARD | ACELYRIN, Inc. | 92,158 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 15,542 | 0.00 USD | deriv |
| 24 Aug 2023 | SALE | Xenon Pharmaceuticals Inc. | 25,000 | 38.70 USD | |
| 09 Jun 2023 | GRANT_AWARD | Avalanche Biotechnologies, Inc. | 40,000 | 0.00 USD | deriv |
| 02 Jun 2023 | GRANT_AWARD | Xenon Pharmaceuticals Inc. | 18,475 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 16 May 2022.